Skip to content

The effect of a long-term period interval and continuous exercise on some markers and inflammatory cytokines in breast cancer survivors

The effect of a long-term period interval and continuous exercise on some markers and inflammatory cytokines in breast cancer survivors

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20190731044398N2
Enrollment
45
Registered
2019-09-05
Start date
2019-08-23
Completion date
Unknown
Last updated
2019-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer. Malignant neoplasm of breast

Interventions

Intervention 1: high intensity interval training group: During the study, this group will perform high intensity interval training for 12 weeks and 3 weeks each week. Intervention 2: moderate intensi

Sponsors

Private
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: A definitive diagnosis of cancer and a history of cancer based on medical records. Exposure to stage one, two or three diseases and completion of treatment courses (Breast Removal Surgery, Chemotherapy, Radiotherapy) at least in the last 6 months Menopause Body mass index more than 25 kg/m2 Body fat more than 30%

Exclusion criteria

Exclusion criteria: Cardiovascular disease Diabetes Thyroid diseases smoking

Design outcomes

Primary

MeasureTime frame
Serum levels of IL-8. Timepoint: Before and after intervention. Method of measurement: Blood sampling and using ELISA method.;Serum levels of Leptin. Timepoint: Before and after intervention. Method of measurement: Blood sampling and using ELISA method.;Serum levels of Adiponectin. Timepoint: Before and after intervention. Method of measurement: Blood sampling and using ELISA method.;Serum levels of IGF-1. Timepoint: Before and after intervention. Method of measurement: Blood sampling and using ELISA method.;Serum levels of IGFBP-3. Timepoint: Before and after intervention. Method of measurement: Blood sampling and using ELISA method.;Serum levels of TAC. Timepoint: Before and after intervention. Method of measurement: Blood sampling and using ELISA method.;Serum levels of MDA. Timepoint: Before and after intervention. Method of measurement: Blood sampling and using ELISA method.;Serum levels of 8-OHdG. Timepoint: Before and after intervention. Method of measurement: Blood sampling and using ELISA method.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactParisa Pournemati?

University of Tehran

p.pournemati@ut.ac.ir+98 21 8835 1730

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026